Insiders Vanda Pharmaceuticals Inc.

Equities

VNDA

US9216591084

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 10/04/2026 BST			5-day change	1st Jan Change
7.220 ^USD	-1.50%		+3.14%	-18.14%

04-09	Vanda Asks FDA to Withdraw Proposal Extending Drug Review Timelines	MT
04-08	Vanda Pharmaceuticals Starts Study of Nereus to Address GLP-1 Side Effects	MT

Insiders

04-02	Vanda Pharmaceuticals Inc. Announces Resignation of Timothy Williams as Senior Vice President, General Counsel and Secretary, Effective April 10, 2026	CI
03-05	Vanda Pharmaceuticals Insider Sold Shares Worth $1,276,971, According to a Recent SEC Filing	MT
17/03/23	Vanda Pharmaceuticals Inc. Appoints Dr. Tage Honoré to its Board of Directors	CI
07/12/22	Insider Sell: Vanda Pharmaceuticals	MT
25/04/22	H. Thomas Watkins Not Stands for Reelection of Vanda Pharmaceuticals Inc	CI
02/12/21	Insider Sell: Vanda Pharmaceuticals	MT
08/10/21	Vanda Pharmaceuticals Inc. Announces Resignation of Aranthan “Aj” Jones II as the Corporate Affairs and Communications Officer	CI
17/09/21	Insider Sell: Vanda Pharmaceuticals	MT
13/09/21	Insider Sell: Vanda Pharmaceuticals	MT
27/07/21	Insider Trends: 90-Day Insider Buying Trend Scaled Back with Sale of Vanda Pharmaceuticals Shares	MT
22/04/20	Vanda Pharmaceuticals Inc. Announces Resignation of Mihael H. Polymeropoulos as Director	CI
03/03/20	Vanda Pharmaceuticals Inc. Announces Resignation of Gian Piero Reverberi as Senior Vice President and Chief Commercial Officer, Effective as of March 16, 2020	CI
20/02/20	Vanda Pharmaceuticals Inc. Announces Executive Changes, Effective March 15, 2020	CI
19/02/20	Vanda Pharmaceuticals Inc. Announces Board Changes	CI
21/01/20	Vanda Pharmaceuticals Announces Resignation of Gian Piero Reverberi as its Senior Vice President, Chief Commercial Officer, Effective March 16, 2020	CI
06/11/19	Vanda Pharmaceuticals Inc. Hires Scott L. Howell as Its Chief People Officer	CI
28/10/19	Vanda Pharmaceuticals Inc. Appoints Anne Sempowski Ward to Board of Directors	CI
21/08/19	Vanda Pharmaceuticals Announces Management Appointments	CI
24/04/19	Vanda Pharmaceuticals Appoints Phaedra Chrousos to Board of Directors	CI
13/08/18	Vanda Pharmaceuticals Inc. Appoints Timothy Williams as Senior Vice President, General Counsel and Secretary	CI
25/04/18	Vanda Pharmaceuticals Inc. Announces Retirement of Kenneth M. Bate from the Board of Directors	CI
23/04/18	Vanda Pharmaceuticals Inc Announces Resignation of Richard L. Gulino as Senior Vice President, General Counsel and Secretary, Effective May 2, 2018	CI
13/03/17	Paolo Baroldi Notifies His Resignation as Chief Medical Officer of Vanda Pharmaceuticals Inc., Effective March 22, 2017	CI
25/03/16	Vanda Pharmaceuticals, Inc. Announces Howard H. Pien Not Stand to Re-Elect as Director	CI
21/12/15	Vanda Pharmaceuticals Inc. Announces Executive Changes	CI